Literature DB >> 11836621

IL-12 or IL-15, unlike IL-2, does not interact with histamine in augmenting cytotoxicity of splenocytes against melanoma cells and YAC-1 cells.

Katarzyna Kozar1, Rafal Kaminski, Adam Giermasz, Grzegorz Basak, Radoslaw Zagozdzon, Jolanta Rybczynska, Maria Wasik, Witold Lasek, Marek Jakobisiak, Jakub Golab.   

Abstract

It has been suggested that histamine by its ability to downregulate the production of macrophage-derived reactive oxygen species might effectively potentiate the cytotoxic activity of cytokine-stimulated NK cells. Histamine thus reverses negative regulation of NK cells treated with IL-2 and IFN-alpha in the presence of macrophages. We confirm that histamine potently enhances cytotoxic activity of IL-2-stimulated NK cell-enriched splenocytes admixed with macrophages against B16F10 melanoma cells and YAC-1 cells. This stimulation results in production of high amounts of INF-gamma and TNF-alpha. Interestingly, IL-15 by itself promotes production of reactive oxygen species. Although histamine decreased reactive oxygen species production from the cultures of IL-15-stimulated NK cell-enriched splenocytes admixed with macrophages, it did not potentiate the cytotoxicity of IL-15. Further, we demonstrate that histamine-mediated potentiation of cytotoxicity is not applicable to IL-12, another potent activator of NK cell activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836621

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

Review 1.  Histamine receptors and cancer pharmacology: an update.

Authors:  Noelia A Massari; Melisa B Nicoud; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2018-12-13       Impact factor: 8.739

2.  Human interleukin-15 improves engraftment of human T cells in NOD-SCID mice.

Authors:  Anyuan Sun; Haiming Wei; Rui Sun; Weihua Xiao; Yongguang Yang; Zhigang Tian
Journal:  Clin Vaccine Immunol       Date:  2006-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.